ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present at the 8th Annual BIO Investor Forum on October 29, 2009, at 11:30 a.m. Eastern Time at the Palace Hotel, San Francisco, CA.
